ITOS Insider Trading
Insider Ownership Percentage: 12.50%
Insider Buying (Last 12 Months): $38,650.00
Insider Selling (Last 12 Months): $0.00
iTeos Therapeutics Insider Trading History Chart
This chart shows the insider buying and selling history at iTeos Therapeutics by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
iTeos Therapeutics Share Price & Price History
Current Price: $5.70
Price Change: ▼ Price Decrease of -0.07 (-1.21%)
As of 04/3/2025 05:00 PM ET
iTeos Therapeutics Insider Trading History
iTeos Therapeutics Institutional Trading History
Data available starting January 2016
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984. The company was founded by Michel Detheux in April 2012 and is headquartered in Watertown, MA.
Read More on iTeos Therapeutics
Volume
309,000 shs
Average Volume
458,596 shs
Market Capitalization
$217.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.43
Who are the company insiders with the largest holdings of iTeos Therapeutics?